BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood
- PMID: 11086035
- DOI: 10.4049/jimmunol.165.11.6037
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood
Abstract
We have generated a panel of mAbs that identify three presumably novel human dendritic cell Ags: BDCA-2, BDCA-3, and BDCA-4. In blood, BDCA-2 and BDCA-4 are expressed on CD11c(-) CD123(bright) plasmacytoid dendritic cells, whereas BDCA-3 is expressed on small population of CD11c(+) CD123(-) dendritic cells. All three Ags are not detectable on a third blood dendritic cell population, which is CD1c(+) CD11c(bright) CD123(dim), or on any other cells in blood. BDCA-4 is also expressed on monocyte-derived and CD34(+) cell-derived dendritic cells. Expression of all three Ags dramatically changes once blood dendritic cells undergo in vitro maturation. BDCA-2 is completely down-regulated on plasmacytoid CD11c(-) CD123(bright) dendritic cells, expression of BDCA-3 is up-regulated on both plasmacytoid CD11c(-) CD123(bright) dendritic cells and CD1c(+) CD11c(bright) CD123(dim) dendritic cells, and expression of BDCA-4 is up-regulated on CD1c(+) CD11c(bright) CD123(dim) dendritic cells. BDCA-2 is rapidly internalized at 37 degrees C after mAb labeling. The three presumably novel Ags serve as specific markers for the respective subpopulations of blood dendritic cells in fresh blood and will be of great value for their further analysis and to evaluate their therapeutic potential.
Similar articles
-
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.J Clin Invest. 2007 Sep;117(9):2517-25. doi: 10.1172/JCI32282. J Clin Invest. 2007. PMID: 17786242 Free PMC article.
-
Expression of dendritic cell markers CD11c/BDCA-1 and CD123/BDCA-2 in coronary artery disease upon activation in whole blood.J Immunol Methods. 2010 Oct 31;362(1-2):168-75. doi: 10.1016/j.jim.2010.09.031. Epub 2010 Oct 1. J Immunol Methods. 2010. PMID: 20888334 Clinical Trial.
-
CD123bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion?J Immunol. 2002 Jul 1;169(1):75-83. doi: 10.4049/jimmunol.169.1.75. J Immunol. 2002. PMID: 12077231
-
Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions.Hum Immunol. 2002 Dec;63(12):1133-48. doi: 10.1016/s0198-8859(02)00752-8. Hum Immunol. 2002. PMID: 12480257 Review.
-
Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage.Front Immunol. 2020 Sep 30;11:559166. doi: 10.3389/fimmu.2020.559166. eCollection 2020. Front Immunol. 2020. PMID: 33101275 Free PMC article. Review.
Cited by
-
Dendritic cells a double-edge sword in autoimmune responses.Front Immunol. 2012 Aug 2;3:233. doi: 10.3389/fimmu.2012.00233. eCollection 2012. Front Immunol. 2012. PMID: 22876246 Free PMC article.
-
Downregulating galectin-3 inhibits proinflammatory cytokine production by human monocyte-derived dendritic cells via RNA interference.Cell Immunol. 2015 Mar;294(1):44-53. doi: 10.1016/j.cellimm.2015.01.017. Epub 2015 Feb 7. Cell Immunol. 2015. PMID: 25684095 Free PMC article.
-
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.Blood. 2021 Mar 11;137(10):1377-1391. doi: 10.1182/blood.2020007897. Blood. 2021. PMID: 32871587 Free PMC article.
-
Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis.Respir Res. 2013 Mar 4;14(1):29. doi: 10.1186/1465-9921-14-29. Respir Res. 2013. PMID: 23497225 Free PMC article.
-
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy.J Immunother Cancer. 2020 Jul;8(2):e000967. doi: 10.1136/jitc-2020-000967. J Immunother Cancer. 2020. PMID: 32675311 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous